Jon A. Olson
Analyst · Nomura
Thank you, Rick. Xilinx sales were $544 million in the September quarter, down 7% sequentially but within our guidance towards the lower end of our guidance. Weaker-than-anticipated sales from industrial and A&D, as well as computer and data processing, more than offset better-than-expected sales from wireless communications. With the exception of Japan, which was flat, sales to all geographies were down sequentially. Turns were 57% for the quarter and relatively linear on a monthly basis. We continue to get the capacity we need from our foundry partners, and our lead times, with a few exceptions, are within normal ranges. Gross margin was 65.5%. This level is a testament to our focus on margin improvement projects across our product portfolio, with particular emphasis on new product margins, which offset significant impact from customer and product mix during the quarter. Operating expenses of $208 million were lower than expected as a result of the shift in tape-out activity, lower litigation expense and reduced discretionary spending. New product sales were up 7% sequentially, with strong growth from our 28-nanometer families while 40-nanometer sales were essentially flat. During the quarter, revenue from our 28-nanometer products achieved our goal, surpassing $20 million. Mainstream products increased 3% during the quarter, with strength from the Virtex-5 products, driven primarily by LTE deployment activity. Base products declined over 20% sequentially, with most of the decreases coming from industrial, defense and communications. Let me now turn to a discussion of end markets. Sales from communications in data center increased 3% sequentially, with strong wireless sales offsetting expected declines in wireline. Industrial and aerospace and defense sales declined 13% sequentially, with declines coming from all 3 subcategories: defense, industrial, scientific, medical and test measurement. Broadcast, consumer and automotive sales declined 15% sequentially, with sales from all categories flat to down sequentially. The other category declined 24% sequentially, impacted by declines in computer and data processing, as well as storage. Net income for the quarter was $123 million or $0.46 per diluted share. Other income and expense was a net expense of $10 million, higher than anticipated due primarily to an unfavorable hedging impact. Operating cash flow for the June quarter was $197 million before $8 million in capital expenditures. We paid $57 million in cash dividends during the quarter and repurchased 2.5 million shares for $79 million. The tax rate during the quarter declined due to a shift in our geographic mix of profits. Our new effective tax rate is 15%. In addition to the lower tax rate estimate for the year, in Q2, we had a favorable impact to tax expense of $4 million associated with the release of reserves related to a recent tax court case. The impact of these 2 factors represent a positive contribution to EPS of approximately $0.03 per share. Diluted shares for the quarter were 270 million. There was a 5.5 million share dilutive effect from our convertible notes. For questions related to the dilution associated with our convertibles, please visit our Investor Relations website at www.investor.xilinx.com. Let me now comment on the balance sheet. Cash and investments increased $61 million to approximately $3.2 billion. We have approximately $1.3 billion in convertible debt, and our net cash position is approximately $1.9 billion. Days sales outstanding decreased 3 days in the September quarter to 37 days. Inventory dollars at Xilinx increased as expected by $11 million sequentially during the quarter. Combined inventory days at Xilinx and distribution were 109, up from 99 days in the prior quarter. We expect inventory days to slightly increase in the December quarter. Let me now turn to a discussion of guidance for the December quarter of fiscal year '13. Our backlog heading into the quarter is down sequentially. Additionally, we believe continued macroeconomic uncertainty may result in unpredictable customer ordering patterns. We expect continued growth in our new products but will most likely experience declines from our base and mainstream products. From an end market perspective, we expect communications to be down sequentially. Within communications, wireless is expected to decline more than wired. Within industrial and aerospace and defense, we expect increases in both industrial occupations and defense. Automotive, consumer and broadcast is expected to be approximately flat. As a result, we are expecting total sales to be down 1% to down 5% sequentially, with sales from North America up, Japan flat, Asia Pacific and Europe down sequentially. The midpoint of our sales guidance is predicated on a turns rate of approximately 59%. Gross margin is expected to be approximately 66%, up slightly from the September quarter, due primarily to improving customer mix. Operating expenses in the December quarter are expected to be approximately $224 million, including $3 million of amortization of acquisition-related intangibles. Almost all the growth from Q2 is related to an increase in map and wafer expense. Q4 operating expense will decline substantially, resulting in combined R&D and SG&A expense of approximately $860 million for the fiscal year 2013, and it's at the low end of the range we provided at our analyst meeting last year. Given the uncertain business environment, we are slowing headcount growth and lowering discretionary spending. Other income and expense is expected to be a net expense of approximately $7 million. The share count is expected to be approximately 269 million shares, and the tax rate is expected to be approximately 15%. Let me now turn the call over to Moshe.